Hangzhou Tigermed Consulting Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

2,032.83

1,982.06

1,940.01

1,819.49

1,672.34

1,660.55

1,860.05

Other Operating Income

0.00

Total Operating income

2,032.83

1,982.06

1,940.01

1,819.49

1,672.34

1,660.55

1,860.05

Raw Material Cost

1,491.31

1,571.03

1,443.08

1,308.51

1,207.12

1,409.88

1,210.10

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

25.01

26.04

14.07

34.02

0.00

7.24

0.00

Selling and Distribution Expenses

261.91

214.00

234.52

232.45

222.17

210.25

222.68

Other Expenses

4.57

4.40

5.34

3.69

6.09

6.18

4.89

Total Expenditure (Excl Depreciation)

1,823.93

1,855.12

1,745.06

1,611.94

1,490.15

1,689.19

1,481.72

Operating Profit (PBDIT) excl Other Income

208.9

126.89999999999999

195

207.60000000000002

182.2

-28.599999999999998

378.29999999999995

Other Income

64.40

-204.27

231.76

232.57

40.54

43.60

-4.98

Operating Profit (PBDIT)

263.00

-0.68

516.44

528.80

310.07

121.04

462.26

Interest

25.01

26.04

14.07

34.02

0.00

7.24

0.00

Exceptional Items

220.08

-330.41

451.11

-72.56

-23.94

-505.33

69.63

Gross Profit (PBDT)

541.52

411.03

496.93

510.98

465.22

250.67

649.95

Depreciation

0.00

101.46

101.07

99.53

98.62

99.31

99.93

Profit Before Tax

458.08

-458.59

852.41

322.68

153.56

-490.84

431.96

Tax

85.60

73.56

55.99

49.87

35.97

35.36

55.95

Provisions and contingencies

0.00

Profit After Tax

55.34

-145.39

696.16

235.08

176.92

-441.54

348.84

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

55.34

-145.39

696.16

235.08

176.92

-441.54

348.84

Share in Profit of Associates

0.00

Minority Interest

317.13

-169.01

100.26

37.74

-59.33

-50.85

27.18

Other related items

0.00

Consolidated Net Profit

372.48

-314.40

796.42

272.82

117.59

-492.38

376.02

Equity Capital

0.00

Face Value

1.13

1.11

1.09

1.1

1.07

1.06

1.11

Reserves

23,738.28

23,344.99

23,145.54

22,485.08

22,025.72

21,997.96

23,320.95

Earnings per share (EPS)

0.06

-0.17

0.81

0.28

0.2

-0.51

0.4

Diluted Earnings per share

0.06

-0.17

0.81

0.28

0.2

-0.51

0.4

Operating Profit Margin (Excl OI)

9.77%

5.15%

9.46%

10.81%

10.22%

-1.32%

19.75%

Gross Profit Margin

22.53%

-18.02%

49.15%

23.21%

15.08%

-23.58%

28.6%

PAT Margin

2.72%

-7.34%

35.88%

12.92%

10.58%

-26.59%

18.75%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.56% vs 2.17% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 218.48% vs -139.48% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -2.46% vs -28.49% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -3.85% vs 84.40% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Hangzhou Tigermed Consulting Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(HKD)

Change(%)

Net Sales

2,032.83

249.43

1,783.40

714.99%

Other Operating Income

0.00

Total Operating income

2,032.83

249.43

1,783.40

714.99%

Raw Material Cost

1,491.31

183.53

1,307.78

712.57%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

25.01

1.02

23.99

2,351.96%

Selling and Distribution Expenses

261.91

61.51

200.40

325.80%

Other Expenses

4.57

-0.10

4.67

4,670.00%

Total Expenditure (Excl Depreciation)

1,823.93

245.04

1,578.89

644.34%

Operating Profit (PBDIT) excl Other Income

208.91

4.40

204.51

4,647.95%

Other Income

64.40

3.34

61.06

1,828.14%

Operating Profit (PBDIT)

263.00

13.06

249.94

1,913.78%

Interest

25.01

1.02

23.99

2,351.96%

Exceptional Items

220.08

408.48

-188.40

-46.12%

Gross Profit (PBDT)

541.52

65.91

475.61

721.61%

Depreciation

0.00

4.73

-4.73

-100.00%

Profit Before Tax

458.08

415.79

42.29

10.17%

Tax

85.60

-3.84

89.44

2,329.17%

Provisions and contingencies

0.00

Profit After Tax

55.34

418.25

-362.91

-86.77%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

55.34

418.25

-362.91

-86.77%

Share in Profit of Associates

0.00

Minority Interest

317.13

-0.01

317.14

3,171,400.00%

Other related items

0.00

Consolidated Net Profit

372.48

418.24

-45.76

-10.94%

Equity Capital

0.00

Face Value

1.13

0.00

Reserves

23,738.28

-135.99

23,874.27

17,555.90%

Earnings per share (EPS)

0.06

0.48

-0.42

-87.50%

Diluted Earnings per share

0.06

0.48

-0.42

-87.50%

Operating Profit Margin (Excl OI)

9.77%

2.00%

0.00

7.77%

Gross Profit Margin

22.53%

168.59%

0.00

-146.06%

PAT Margin

2.72%

167.68%

0.00

-164.96%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 203.28 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 2.56% vs 2.17% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 21.56% vs -7.41% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 37.25 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 218.48% vs -139.48% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 216.75% vs -65.42% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 19.86 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -2.46% vs -28.49% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -26.31% vs -38.81% in Mar 2025

Quarterly - Interest

Interest 2.50 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -3.85% vs 84.40% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 9.77%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025